There are three major issues facing congress and the president in the prescription drug area:1) Importation of drugs from safe countries; 2) Medicare putting its drugs out for bid : 3) Blocking payoffs or deals of drug companies to generic drug manufacturers not to produce. There are now eight bills, many bi partisan, in the Senate and five in the House addressing these matters.
Why aren’t these bills moving? It appears many in key positions in congress appear to be more interested in campaign contributions from Pharma than the public good.
None of the bills on these issues represent a budget increase; most are savings. How can congress talk about Medicare cuts when billions of dollars in savings can be made over the next ten years? Let’s get these bills moving, the public is tired of inaction in this area.
Joseph Dombrowski
Scottsdale
